Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

3801-3810 of 4090 results

Catalogue Number:

PX-TA1711

Category:

G

Proteo Genix logo

Ripertamab Biosimilar – Anti-MS4A1 mAb – Research Grade

Target: MS4A1
Target Alias Name: Ripertamab/IMMUNOGLOBULIN G1-KAPPA/ ANTI-(HOMO SAPIENS MS4A1 (MEMBRANE-SPANNING 4-DOMAINS SUBFAMILY A MEMBER 1/ CD20))/ CHIMERIC MONOCLONAL ANTIBODY/ IMMUNOGLOBULIN IGG1/ ANTI-(HUMAN CD20 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL DISULFIDE SCT400 .GAMMA.1-CHAIN)/ DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SCT400 .KAPPA.-CHAIN/ DIMER/ SCT-400/MS4A1/anti-MS4A1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1396

Category:

G

Proteo Genix logo

Risankizumab Biosimilar – Anti-IL23A mAb – Research Grade

Target: IL23A
Target Alias Name: Risankizumab/BI 655066/risankizumab-rzaa/IL23A/anti-IL23A
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1010

Category:

G

Proteo Genix logo

Rituximab Biosimilar – Anti-MS4A1 mAb – Research Grade

Target: MS4A1
Target Alias Name: Rituximab/Rituximab/MS4A1/anti-MS4A1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1416

Category:

G

Proteo Genix logo

Rivabazumab Biosimilar – Anti-PcrV mAb – Research Grade

Target: PcrV
Target Alias Name: Rivabazumab/BA1126/PcrV/anti-PcrV
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: Fab'-G1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1210

Category:

G

Proteo Genix logo

Robatumumab Biosimilar – Anti-IGF1R/ CD221 mAb – Research Grade

Target: IGF1R/ CD221
Target Alias Name: Robatumumab/19D12/SCH 717454/IGF1R/ CD221 /anti-IGF1R/ CD221
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1784

Category:

G

Proteo Genix logo

Rocatinlimab Biosimilar – Anti-CD134 mAb – Research Grade

Target: CD134
Target Alias Name: Rocatinlimab/KHK 4083/ KHK-4083/ KHK4083/CD134/anti-CD134
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA2137

Category:

G

Proteo Genix logo

Roconkibart Biosimilar – Anti-CTLA-8 mAb – Research Grade

Target: CTLA-8
Species Reactivity: Human
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1249

Category:

G

Proteo Genix logo

Roledumab Biosimilar – Anti-RHD mAb – Research Grade

Target: RHD
Target Alias Name: Roledumab/LFB-R593/RHD/anti-RHD
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1535

Category:

G

Proteo Genix logo

Rolinsatamab Biosimilar – Anti-PRLR mAb – Research Grade

Target: PRLR
Target Alias Name: Rolinsatamab/PR-1594804/h16f/PRLR/anti-PRLR
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1971

Category:

G

Proteo Genix logo

Rolistobart Biosimilar – Anti-CD85 antigen-like family member K mAb – Research Grade

Target: CD85 antigen-like family member K
Target Alias Name: anti-CD85 antigen-like family member K/ LIR-5/ Leukocyte immunoglobulin-like receptor 5/ ILT3/ ILT-3/ Immunoglobulin-like transcript 3/ LILRB4/ CD85k/ Leukocyte immunoglobulin-like receptor subfamily B member 4/ Monocyte inhibitory receptor HM18/ LIR5
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo